Market revenue in 2023 | USD 545.7 million |
Market revenue in 2030 | USD 997.7 million |
Growth rate | 9% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | OUTPATIENT FACILITIES |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | HOSPITALS, OUTPATIENT FACILITIES |
Key market players worldwide | Cochlear Ltd, Sonova Holding AG, Demant A/S, Amplifon SpA Az nom Post Frazionamento, MED-EL, Zhejiang Pushkang Biotechnology Co. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cochlear implant market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 88.02% in 2023. Horizon Databook has segmented the North America cochlear implant market based on hospitals, outpatient facilities covering the revenue growth of each sub-segment from 2018 to 2030.
Some of the key factors contributing to the North America cochlear implant market growth include technological advancements, reimbursement coverage, and greater spending capacity, resulting in high adoption of cochlear implant devices.
In addition, the availability of skilled surgeons and well-equipped clinics is another factor propelling the growth in the region. Moreover, key companies in the region are developing products that can provide profound treatment to cochlear implant patients, along with developing sound processors with dual microphones.
For instance, in June 2021, Demant A/S’s Oticon Medical announced that its “Neuro Cochlear Implant System” received premarket approval from the U.S. FDA. The new implant system is intended for patients 18 years and older with bilateral severe-to-profound sensorineural hearing loss or limited hearing ability. This device will help patients listen better without disturbances and noise.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America cochlear implant market , including forecasts for subscribers. This continent databook contains high-level insights into North America cochlear implant market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account